About VitamFero
VitamFero is a company based in Angers (France) founded in 2005 by Alain De La Bigne. It operates as a B2B. VitamFero has raised $6.72 million across 5 funding rounds from investors including GO CAPITAL, European Union and EIC Fund. VitamFero operates in a competitive market with competitors including Merck Animal Health, TARGAN, ViroVet, Intervacc and Pacific GeneTech, among others.
- Headquarter Angers, France
- Founders Alain De La Bigne
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$6.72 M (USD)
in 5 rounds
-
Latest Funding Round
$55.82 K (USD), Grant
Aug 31, 2016
-
Investors
GO CAPITAL
& 4 more
-
Employee Count
Not available
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Funding Insights of VitamFero
VitamFero has successfully raised a total of $6.72M across 5 strategic funding rounds. The most recent funding activity was a Grant round of $55.82 thousand completed in August 2016. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in VitamFero
VitamFero has secured backing from 5 investors, including venture fund and institutional investors. Prominent investors backing the company include GO CAPITAL, European Union and EIC Fund.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Government agency and accelerator focusing on innovative startups and SMEs
|
Locked | Locked | Locked | |
|
Capagro is focused on venture capital investments in AgTech and FoodTech.
|
Locked | Locked | Locked | |
|
Private equity investments are directed toward multiple sectors.
|
Locked | Locked | Locked |
Investor details for VitamFero
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by VitamFero
Investment portfolio details for VitamFero
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - VitamFero
Detailed financials for VitamFero
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Vitamfero Comparisons
Peer comparison for VitamFero
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of VitamFero
VitamFero operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Merck Animal Health, TARGAN, ViroVet, Intervacc and Pacific GeneTech, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Vaccine technology is developed and supplied for livestock animals.
|
|
| Locked | Locked | Locked |
Automated targeted vaccine systems for livestock and aquaculture are developed.
|
|
| Locked | Locked | Locked |
Manufacturer and supplier of antiviral drugs for livestock
|
|
| Locked | Locked | Locked |
Recombinant vaccines for cattle, equine, and other livestock are developed.
|
|
| Locked | Locked | Locked |
Developer of vaccines and gene delivery platform
|
Detailed competitors of VitamFero
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Vitamfero
Complete news archive for VitamFero
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about VitamFero
VitamFero was founded in 2005 and raised its 1st funding round 6 years after it was founded.
VitamFero is headquartered in Angers, France. It is registered at Angers, Pays De La Loire, France.
VitamFero is a funded company, having raised a total of $6.72M across 5 funding rounds to date.
VitamFero, established in 2005, excels in providing healthcare solutions, veterinary, livestock vaccines, and immunostimulating products. Offers patented immunostimulating vaccines for livestock. Committed to advancing standards, it focuses on innovation, efficiency, and delivering value to clients worldwide. It continues to evolve, meeting industry challenges with strategic approaches.
VitamFero's top competitors include TARGAN, Merck Animal Health and Intervacc.
VitamFero has 5 investors. Key investors include GO CAPITAL, European Union, EIC Fund, Capagro, and Karista.